Article
The Role of Gut Microbiome on Glioblastoma Oncogenesis and Malignant Evolution
24 Mar 2025
Abstract excerpt
Glioblastoma (GBM) remains the most aggressive primary brain tumor, with poor survival outcomes and treatment limited to maximal safe surgical resection, chemotherapy with temozolomide, and radiotherapy. While immunotherapy and targeted treatments show promise, therapeutic resistance and disease progression remain major challenges. This is partly due to GBM's classification as a "cold tumor" with low mutational...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
